image
Healthcare - Medical - Devices - NASDAQ - US
$ 7.52
-9.18 %
$ 310 M
Market Cap
-6.43
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one VREX stock under the worst case scenario is HIDDEN Compared to the current market price of 7.52 USD, Varex Imaging Corporation is HIDDEN

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one VREX stock under the base case scenario is HIDDEN Compared to the current market price of 7.52 USD, Varex Imaging Corporation is HIDDEN

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one VREX stock under the best case scenario is HIDDEN Compared to the current market price of 7.52 USD, Varex Imaging Corporation is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart VREX

image
$17.0$17.0$16.0$16.0$15.0$15.0$14.0$14.0$13.0$13.0$12.0$12.0$11.0$11.0$10.0$10.0$9.0$9.0$8.0$8.0$7.0$7.015 Oct15 OctNov '24Nov '2415 Nov15 NovDec '24Dec '2415 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '25
FINANCIALS
811 M REVENUE
-9.22%
32.1 M OPERATING INCOME
-58.37%
-47.2 M NET INCOME
-96.92%
47.3 M OPERATING CASH FLOW
-56.37%
-27.5 M INVESTING CASH FLOW
38.75%
-3.3 M FINANCING CASH FLOW
-1550.00%
200 M REVENUE
-2.87%
11.2 M OPERATING INCOME
2.75%
-100 K NET INCOME
99.80%
9.5 M OPERATING CASH FLOW
-63.18%
-3 M INVESTING CASH FLOW
78.57%
125 M FINANCING CASH FLOW
13777.78%
Balance Sheet Varex Imaging Corporation
image
Current Assets 650 M
Cash & Short-Term Investments 200 M
Receivables 158 M
Other Current Assets 292 M
Non-Current Assets 567 M
Long-Term Investments 26.8 M
PP&E 182 M
Other Non-Current Assets 359 M
16.47 %12.96 %23.97 %14.93 %29.47 %Total Assets$1.2b
Current Liabilities 196 M
Accounts Payable 59.1 M
Short-Term Debt 50.3 M
Other Current Liabilities 86.5 M
Non-Current Liabilities 472 M
Long-Term Debt 420 M
Other Non-Current Liabilities 51.8 M
8.85 %7.53 %12.95 %62.91 %7.76 %Total Liabilities$667.8m
EFFICIENCY
Earnings Waterfall Varex Imaging Corporation
image
Revenue 811 M
Cost Of Revenue 554 M
Gross Profit 257 M
Operating Expenses 225 M
Operating Income 32.1 M
Other Expenses 79.3 M
Net Income -47.2 M
900m900m800m800m700m700m600m600m500m500m400m400m300m300m200m200m100m100m00(100m)(100m)811m(554m)257m(225m)32m(79m)(47m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
31.68% GROSS MARGIN
31.68%
3.96% OPERATING MARGIN
3.96%
-5.88% NET MARGIN
-5.88%
-8.91% ROE
-8.91%
-3.92% ROA
-3.92%
-28.28% ROIC
-28.28%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Varex Imaging Corporation
image
90m90m80m80m70m70m60m60m50m50m40m40m30m30m20m20m10m10m00(10m)(10m)(20m)(20m)20162016201720172018201820192019202020202021202120222022202320232024202420252025
Net Income -47.2 M
Depreciation & Amortization 31.1 M
Capital Expenditures -26.9 M
Stock-Based Compensation 15.3 M
Change in Working Capital 2 M
Others 1 M
Free Cash Flow 20.4 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Varex Imaging Corporation
image
Wall Street analysts predict an average 1-year price target for VREX of $17 , with forecasts ranging from a low of $17 to a high of $17 .
VREX Lowest Price Target Wall Street Target
17 USD 126.06%
VREX Average Price Target Wall Street Target
17 USD 126.06%
VREX Highest Price Target Wall Street Target
17 USD 126.06%
Price
Max Price Target
Min Price Target
Average Price Target
181817171616151514141313121211111010998877May '24May '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 15
6. Ownership
Insider Ownership Varex Imaging Corporation
image
Sold
0-3 MONTHS
150 K USD 2
3-6 MONTHS
0 USD 0
6-9 MONTHS
32.3 K USD 1
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
207 K USD 1
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Should Value Investors Buy VAREX IMAGING (VREX) Stock? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. zacks.com - 2 months ago
Varex Imaging Corporation (VREX) Q1 2025 Earnings Call Transcript Varex Imaging Corporation (NASDAQ:VREX ) Q1 2025 Earnings Conference Call February 6, 2024 5:00 PM ET Company Participants Christopher Belfiore - Director, IR Sunny Sanyal - President and CEO Shubham Maheshwari - CFO Conference Call Participants Young Li - Jefferies Kyle Bauser - B. Riley Securities Larry Solow - CJS Securities Suraj Kalia - Oppenheimer James Sidoti - Sidoti & Company Operator Greetings and welcome to the Varex First Quarter Fiscal Year 2025 Earnings Call and Webcast. seekingalpha.com - 2 months ago
VAREX IMAGING (VREX) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates Although the revenue and EPS for VAREX IMAGING (VREX) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. zacks.com - 2 months ago
VAREX IMAGING (VREX) Q1 Earnings Surpass Estimates VAREX IMAGING (VREX) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of $0.04 per share. This compares to earnings of $0.06 per share a year ago. zacks.com - 2 months ago
Varex Announces Financial Results for First Quarter Fiscal Year 2025 SALT LAKE CITY--(BUSINESS WIRE)--Q1FY25 Earnings Release. businesswire.com - 2 months ago
Varex Management to Participate in Upcoming Investor Conferences SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) announced today that management is scheduled to participate in the following upcoming investor conferences. BTIG at Snowbird: The 12th Annual MedTech, Digital Health, LS&D Tools Conference in Salt Lake City, UT – Wednesday, February 12, 2025 (1x1 meetings only) B. Riley Securities Precision Oncology & Radiopharma Conference – Friday, February 28, 2025 in New York, NY (1x1 meetings only) About Varex Varex Imaging C. businesswire.com - 2 months ago
Varex Schedules First Quarter Fiscal Year 2025 Earnings Release and Conference Call SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) today announced that it will report unaudited financial results for the first quarter of fiscal year 2025 following the close of regular trading on Thursday, February 6, 2025. The earnings news release will be followed by a conference call at 3:00 pm Mountain Time that day. This call will be webcast live and can be accessed at the company's website at www.vareximaging.com/investor-relations/. Investors can also access thi. businesswire.com - 2 months ago
Varex to Participate in CJS Securities 25th Annual New Ideas for the New Year Virtual Conference SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) announced today that management is scheduled to present at the CJS Securities 25th Annual New Ideas for the New Year Virtual Conference. Management will be presenting on Tuesday, January 14, 2025 at 2:20pm ET. The webcast can be accessed here or on Varex's website at www.vareximaging.com/news. About Varex Varex Imaging Corporation is a leading innovator, designer, and manufacturer of X-ray imaging components, which includ. businesswire.com - 3 months ago
Varex Announces Pricing of Private Offering of $125 Million of Senior Secured Notes SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) today announced it has priced a private offering (the “Offering”) of $125 million aggregate principal amount of 7.875% senior secured notes due October 15, 2027 (the “notes”) at an offering price of 101.5% of the principal amount thereof, plus accrued and unpaid interest from October 15, 2024. The notes offered hereby will be issued as “Additional Notes” under the Indenture and will constitute a further issuance of our 7. businesswire.com - 4 months ago
Varex to Hold Virtual Annual Meeting of Stockholders and Sets Annual Meeting and Record Dates SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) today announced that its 2025 Annual Meeting of Stockholders will be held in virtual format only at 4:30 pm Mountain Time on Thursday, February 13, 2025. Stockholders will not be able to attend the 2025 annual meeting in person. Varex stockholders of record at the close of business on December 16, 2024 will be entitled to receive notice of the Annual Meeting and to vote upon matters considered at the meeting. Varex will m. businesswire.com - 4 months ago
Varex Introduces LUMEN HD and LUMEN HD Pro: Radiography Detectors Built for the New Demands in Imaging SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) is proud to introduce the LUMEN HD and LUMEN HD Pro digital radiography detectors, designed to meet the evolving standards of healthcare imaging. As the demands of medical imaging continue to shift, these detectors are built to offer reliable, fast, and user-friendly performance in today's cost-conscious environment. Key Features and Benefits: Reliable. The LUMEN family of detectors are designed for uninterrupted flow of. businesswire.com - 4 months ago
Varex Imaging Corporation (VREX) Q4 2024 Earnings Call Transcript Varex Imaging Corporation (NASDAQ:VREX ) Q4 2024 Earnings Conference Call November 19, 2024 5:00 PM ET Company Participants Christopher Belfiore - Director of Investor Relations Sunny Sanyal - President and Chief Executive Officer Shubham Maheshwari - Chief Financial Officer Conference Call Participants Suraj Kalia - Oppenheimer & Co Kyle Bauser - B. Riley Securities Jim Sidoti - Sidoti & Company Larry Solow - CJS Securities Operator Greetings, and welcome to the Varex Fourth Quarter Fiscal Year 2024 Earnings Call. seekingalpha.com - 5 months ago
8. Profile Summary

Varex Imaging Corporation VREX

image
COUNTRY US
INDUSTRY Medical - Devices
MARKET CAP $ 310 M
Dividend Yield 0.00%
Description Varex Imaging Corporation designs and manufactures X-ray imaging components. The company operates in two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components comprising X-ray tubes, digital detectors, high voltage connectors, image-processing software and workstations, 3D reconstruction and computer-aided diagnostic software, collimators, automatic exposure control devices, generators, heat exchangers, ionization chambers, and buckys. This segment's products are used in a range of applications, including radiographic and fluoroscopic imaging, mammography, computed tomography, radiation therapy, oncology, CT, cardiac, surgery, dental, computer-aided detection, and other diagnostic radiography uses. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital detectors, and high voltage connectors for use in security and industrial inspection applications, such as airport security, cargo screening at ports and borders, and nondestructive testing and examination in various applications. Varex Imaging Corporation sells its products through imaging system original equipment manufacturers, independent service companies, and distributors, as well as directly to end-users. The company has operations in North America, South America, Europe, Russia, the Middle East, India, Africa, Asia, and Australia. Varex Imaging Corporation was founded in 2016 and is based in Salt Lake City, Utah.
Contact 1678 South Pioneer Road, Salt Lake City, UT, 84104 https://www.vareximaging.com
IPO Date Jan. 23, 2017
Employees 2300
Officers Ms. Kimberley E. Honeysett J.D. Chief Legal Officer, General Counsel & Corporate Secretary Mr. Christopher John Belfiore Director of Investor Relations Mr. Mark S. Jonaitis Senior Vice President & GM of X-Ray Sources Mr. Shaohua Liang Vice President & MD for China Mr. Andrew J. Hartmann Senior Vice President & GM of X-ray Detectors Mr. Sunny S. Sanyal President, Chief Executive Officer & Director Mr. Shubham Maheshwari Chief Financial Officer & Principal Accounting Officer Ms. Karen Aranki Chief Human Resources Officer